FDA approves Probuphine, a six-month maintenance treatment

August 19, 2016

A couple months late on this one, but back in July, a new type of buprenorphine treatment received FDA approval. The drug is branded under the name Probuphine and is being marketed as a buprenorphine implant that will last for 6-months, requiring only 2 treatments per year. This is an interesting development because both methadone and oral buprenorphine (Suboxone) maintenance - the two most dominant types of maintenance treatment for opioid addiction - both require that the patient dose daily.

Below was taken from an article about Probuphine on drugrehab.org. The page contains a lot of info and covers the most frequently asked questions. Read more below and check out the rest of the page, as it looks like a good starting resource to learn about this new opiate addiction treatment method.

FDA approves Probuphine, a six-month maintenance treatment
drugrehab.org - July 14, 2016

Death from opioid abuse – including heroin and prescription painkillers – is at an all-time high in the United States. But a new treatment option could be a "game changer" in the fight against opioid addiction, experts say.

Probuphine®, a tiny implant inserted into the arm, delivers a constant low dose of buprenorphine – a medication already used to treat opioid addiction – for six months.

The implant offers advantages over taking a daily pill or sublingual film of buprenorphine. Treatment compliance is far less of a challenge, since patients can't skip, forget or abuse their medication. They also don't have to deal with getting a prescription refilled. Some doctors say the implant is safer and easier to tolerate because it delivers even levels of buprenorphine into the bloodstream. The long-acting implant also reduces the risk of accidental ingestion by a child, and diversion of buprenorphine for illegal resale.

Continue reading at drugrehab.org...

Where do calls go?

For those seeking addiction treatment for themselves or a loved one, our OpiateAddictionResource.com helpline is a private, convenient solution.

Calls to any general helpline (non-facility specific 1-8XX numbers) for your visit will be answered by an admissions representative of Treatment Management Company, a paid sponsor of OpiateAddictionResource.com, to help determine whether their treatment programs are an option for you.

Calls to any specific treatment center listed within our directory are answered directly by those facilities.

Our helpline is offered at no cost to you and carries no obligation to enter into treatment. No commission or other fee is ever paid to OpiateAddictionResource.com that is dependent upon whether you enter treatment, or which treatment provider you ultimately choose.